PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPancreatic neoplasms
MeSH D010190 - pancreatic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010182:Pancreatic diseases
0 Companies
0 Drugs
Success rate
D004067:Digestive system neoplasms
0 Companies
0 Drugs
Success rate
D004701:Endocrine gland neoplasms
0 Companies
0 Drugs
Success rate
D010190: 
Pancreatic neoplasms
64 Companies
13 Drugs
$
Success rate
D000077779:Pancreatic intraductal neoplasms
0 Companies
0 Drugs
Success rate
D007516:Islet cell adenoma
0 Companies
0 Drugs
Success rate
D018273:Islet cell carcinoma
7 Companies
2 Drugs
$
Success rate
D021441:Pancreatic ductal carcinoma
20 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaFluorouracil Adrucil  1991-10-18   
Docetaxel Docetaxel  2015-09-16   
Docetaxel Docetaxel Teva  2010-01-26   
Docetaxel Docetaxel Teva Pharma  2011-01-21   
Fluorouracil Fluorouracil  2000-01-27   
Ifosfamide, Mesna Ifosfamide/mesna  2002-02-26   
Sunitinib Sunitinib  2021-11-30   
Tamoxifen Tamoxifen  2003-04-28   
Octreotide Octreotide  2023-12-05   
Irinotecan Irinotecan  2008-02-27   
Novast LaboratoriesFluorouracil Fluorouracil  2019-12-12   
Docetaxel Docetaxel  2017-08-31   
Irinotecan Irinotecan  2017-05-26   
Taro PharmaceuticalFluorouracil Fluorouracil  2003-11-05   
IngenusDocetaxel Docetaxel 2036-03-14 2022-11-22   
MylanDocetaxel Docetaxel  2023-05-11   
Docetaxel Docetaxel Mylan  2012-01-31   
Octreotide Octreotide  2011-02-10   
Sunitinib Sunitinib  2021-12-06   
Tamoxifen Tamoxifen  2003-02-20   
Rising PharmaceuticalsFluorouracil Fluorouracil  2015-04-20   
Ifosfamide Ifosfamide  2012-11-26   
Mayne GroupTamoxifen Soltamox  2005-10-29   
RocheErlotinib Tarceva  2005-09-19 $180.177 M Y2020 
SandozDocetaxel Docetaxel  2011-06-29   
Fluorouracil Fluorouracil  2011-05-02   
Irinotecan Irinotecan  2008-02-27   
AstraZenecaTamoxifen Nolvadex  1982-01-01   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
70%
184/261
Phase 2
22%
62/282
Phase 3
34%
30/88
Approved: 11Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Docetaxel
Mylan
Docetaxel
Roche
Erlotinib,
Ado-trastuzumab emtansine,
Antithrombin iii,
Tiragolumab,
ETRUMADENANT,
Aspartame,
Bevifimod,
Nepidermin,
Pegvorhyaluronidase alfa,
SELICRELUMAB,
Simlukafusp alfa,
Retinol,
Licorice,
PHY906,
Q2w,
Folinoral,
Ro7515629,
Bolus,
Fluoropyrimidine,
Bdb001,
Evidence
AstraZeneca
Tamoxifen,
Albumin,
Antithrombin iii,
Datopotamab deruxtecan,
Camizestrant,
Cilmostim,
Aglatimagene besadenovec,
Cediranib,
Galunisertib,
Saracatinib,
Ademetionine,
Vicriviroc,
Carmellose,
ADAVOSERTIB,
Ceralasertib,
Carboxymethylcellulose,
Bevifimod,
DANVATIRSEN,
Naptumomab estafenatox,
Patidegib,
Telbermin,
Zoptarelin doxorubicin,
Retinol,
Ds-1062,
Corticoids,
Caelyx,
Viaject,
Doxorubin,
CMG901,
Fmiso,
Hiltonol,
Azd0901,
AZD5153,
Folinoral,
Sbrt,
Tmz,
Hydroxydaunomycin,
Bolus,
Cc5013,
Docetaxol,
Evidence,
Iclc
Novartis
Everolimus,
Octreotide acetate,
Octreotide,
Benzocaine,
Transplatin,
Lutetium dotatate lu-177,
Albumin,
Antithrombin iii,
Cilmostim,
Tozadenant,
Spartalizumab,
Dovitinib,
Buparlisib,
Ademetionine,
Vatalanib,
Somatostatin,
Sodium chloride,
Aspartame,
Bevifimod,
Nadide,
Retinol,
Islets,
WNT974,
Chg,
Endocrine,
NIR178,
Q2w,
Hcq,
LCL161,
Folinoral,
Arm1,
Arm2,
Hidroxicloroquina,
LGK974,
Tdm
Sanofi
Docetaxel,
Transplatin,
Ziv-aflibercept,
Tusamitamab ravtansine,
Doconexent,
ALOMFILIMAB,
Bevifimod,
Larotaxel,
Retinol,
Sar-408701,
Gemox,
Folinoral,
Sbrt,
Beam,
Bolus,
Capox,
Docetaxol,
Lmwh
Bausch Health Companies
Fluorouracil,
Antithrombin iii
Pfizer
Docetaxel,
Sunitinib,
Irinotecan hydrochloride trihydrate,
Irinotecan,
Sunitinib malate,
Irinotecan hydrochloride,
Transplatin,
Albumin,
Sasanlimab,
Aglatimagene besadenovec,
Ganitumab,
Evofosfamide,
Ademetionine,
Tacedinaline,
Doconexent,
ULIXERTINIB,
Bevifimod,
Gedatolisib,
PONSEGROMAB,
Ag013736,
Q2w,
Amchafibrin,
Hcq,
Pd0332991,
Hidroxicloroquina
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use